Dr Lal Pathlabs (LALPATHLAB)
STALWARTFairStock Score: 55/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,431.05 |
| Market Cap | ₹23,456.03 Cr |
| P/E Ratio | 42.75 |
| ROCE | 28.88% |
| ROE | 24.32% |
| Dividend Yield | 0.86% |
| Profit Growth | 26.75% |
| Debt/Equity | 0.07 |
| Sales Growth | 10.76% |
| Free Cash Flow | ₹26,600 Cr |
| Promoter Holding | 53.21% |
| 52-Week Range | ₹1,272.6 — ₹1,770 |
| Sector | Healthcare Services |
| Book Value | ₹129.67 |
Dr Lal Pathlabs trades with a P/E ratio of 42.75, ROCE of 28.88%, ROE of 24.32%, profit growth of 26.75%, debt-to-equity of 0.07. The FairStock Score of 55/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer